BeyondSpring Pharmaceuticals Inc.

BYSI:NASDAQ

BeyondSpring is a global clinical stage biopharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from collaboration with University of Washington in de novo drug discovery using ubiquitination platform.

streetwise book logo Streetwise Company Fact Sheet

2024/5/27 3:38:01

(BYSI:NASDAQ)